Search results for: "Novo Nordisk"

(283 records)

Four UK pharma firms breach ABPI Code

Novartis Pharmaceuticals UK, Novo Nordisk, Eli Lilly and Boehringer Ingelheim have breached the Association of the British Pharmaceutical Industry (ABPI) Code of Practice in...

Novo Nordisk reports solid Q1 sales growth

Danish biopharmaceuticals and diabetes care specialist Novo Nordisk increased sales by 18% to Euro 1.7bn in the first quarter of 2009, led by modern insulins and NovoSeven....

Novo Nordisk puts US$400m into China insulin plant

Novo Nordisk is to invest US400m (Euro 310m) in a new insulin production facility in China.

Novo Nordisk acquires IP rights from Neose Technologies

Novo Nordisk in Denmark, has signed an agreement to acquire intellectual property rights from Neose Technologies Inc. related to Neose\'s proprietary GlycoPEGylation technology.

Novo Nordisk launches next generation prefilled insulin pen

Novo Nordisk has launched a next generation of the FlexPen insulin injection device, incorporating new features providing improved safety, convenience and ease of use.

Ark opens new manufacturing facility in Finland

UK-based Ark Therapeutics Group has opened its new commercial-scale manufacturing facility (GMP 3) in Kuopio, Finland.

Novo Nordisk files for regulatory approval of liraglutide in both the US and Europe

Novo Nordisk has filed a New Drug Application (NDA) in the US and a marketing authorisation application in Europe for liraglutide, a once-daily human GLP-1 analogue, for the...

Novo Nordisk donation aids efforts to combat neglected diseases

Novo Nordisk has entered into a scientific collaboration that will benefit both Chinese pharmaceutical development and World Health Organization (WHO) efforts to combat...

Genmab to buy PDL BioPharma's antibody manufacturing facility

Danish biotech company Genmab has entered into an agreement with US-based PDL BioPharma to acquire PDL's antibody manufacturing facility located in Brooklyn Park, Minnesota,...

Phase 2 study shows liraglutide reduces weight

Novo Nordisk has presented clinical results from a double-blind, placebo-controlled phase 2 study comparing liraglutide, the once-daily human GLP-1 analogue, with orlistat, a...

Applications published 14 March 2007

Sapphire Therapeutics licenses Ghrelin antagonist programme from Novo Nordisk

New Jersey-based Sapphire Therapeutics, a private biopharmaceutical company that develops medicines acting on the ghrelin receptor for metabolic and oncologic diseases, has...

Pfizer is world's biggest spender on r&d

Pfizer has become the world's biggest spender on r&d, overtaking US automotive group Ford, according to the European Commission's latest annual scoreboard for industrial r&d...
Recruitment
On the move in October

On the move in October

Millipore and Novo Nordisk expand human insulin supply agreement

US-based Millipore Corporation is expanding its agreement with Novo Nordisk to provide the biopharmaceutical market with recombinant human insulin, a key cell culture...

Novo Nordisk expands manufacturing facility in US

Novo Nordisk has opened its US$100m, 200,000 ft2 expanded facility in Clayton, North Carolina, to meet the country\'s increasing demand for FlexPen prefilled insulin pen.

Trending Articles

  1. Nicox’s NCX 470 new drug application submitted in the United States by Kowa The submission is based on positive results from two Phase III clinical trials (Mont Blanc and Denali)
  2. Thermo Fisher's Patheon becomes exclusive third-party CDMO for KinetiSol technology The agreement will install KinetiSol Formulator equipment across Patheon's Bend and Cincinnati OSD sites, offering pharma customers an integrated development-to-commercial pathway for poorly soluble drug candidates
  3. You need to be a subscriber to read this article.
    Click here to find out more.
    Annex 1 at the transfer point: how to meet the evolving evidence challenge As Annex 1 raises expectations for contamination control, transfer-point evidence must become more dynamic, connected and defensible throughout the entire product lifecycle
  4. Sanofi offers EU commitments for flu vaccine disparagement claims Sanofi has proposed remedies to EU antitrust regulators after allegations it disparaged rival CSL Seqirus's Fluad vaccine in Germany and France since 2024
  5. You need to be a subscriber to read this article.
    Click here to find out more.
    Back to basics: a simple guide to checkweighing in pharmaceutical production Mettler-Toledo’s Miriam Krechlok tells Dr Kevin Robinson how checkweighing helps pharmaceutical manufacturers to verify product completeness, control fill levels and maintain compliance, safety and efficiency

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all

You may also like

Digital The AI-driven biotech and China Medical System have struck a second collaboration in three months, targeting a mass-market CNS indication via a novel mechanism identified by...
Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Insilico Medicine and CMS deepen AI drug discovery tie-up with new CNS collaboration

Read more
Research & Development The global study builds on US POINTER trial findings, testing whether adding a metabolism-targeting drug to structured lifestyle programmes can further reduce cognitive decline...
Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Alzheimer’s Association launches $100m trial combining lifestyle changes and GLP-1s to prevent cognitive decline

Read more
Manufacturing Piramal Pharma Limited (PPL) (NSE: PPLPHARMA | BSE: 543635), a leading global pharmaceutical, health and wellness company, released its Annual Report for FY2026, highlighting a...
Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Piramal Pharma's FY2026 Annual Report showcases global scale, innovation-led growth and sustainability milestones

Read more
Manufacturing The FDA's pre-licence inspection approval of WuXi Biologics' MFG8 facility will strengthen the CRDMO's commercial manufacturing network, supporting the global supply of a...
WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

WuXi Biologics' Hebei facility secures FDA PLI approval for commercial autoimmune biologics manufacturing

Read more
Manufacturing Boehringer Ingelheim has selected the osapiens HUB for Mobile Maintenance for its global, regulated manufacturing operations
Boehringer Ingelheim standardises plant maintenance globally with osapiens

Boehringer Ingelheim standardises plant maintenance globally with osapiens

Read more
Manufacturing With throughput up to 100 kg/h, the new twin-screw extruder brings lab-grade process understanding into pilot-scale production, enabling users to validate process parameters...
Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Brabender TwinLab B-TSE-S 30/40: Pilot-scale extrusion with lab-level insight

Read more
Dosage Forms While injection pens and weight-loss pills are gaining ground across the Western world, the debate focuses one-sidedly on the kilos and not on the body’s health and the...
Obesity medication: fast results … but at the expense of long-term health

Obesity medication: fast results … but at the expense of long-term health

Read more
Pharmaceutical The agreement will expand Teva’s biosimilars pipeline, with the company securing exclusive commercialisation rights for Polpharma Biologics’ proposed ocrelizumab biosimilar...
Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Teva and Polpharma Biologics sign global licensing deal for Ocrevus biosimilar candidate

Read more